425: CoreWeave CEO Updates on Core Scientific Acquisition

CoreWeave's CEO, Michael Intrator, posted a LinkedIn update regarding the proposed acquisition of Core Scientific, referencing key SEC filings and associated risks.

Summary

• CoreWeave, Inc. filed a Form 425 communication related to its proposed acquisition of Core Scientific, Inc.
• The communication was a LinkedIn post by CoreWeave CEO Michael Intrator on October 7, 2025, concerning the acquisition and other related activities.
• Investors are directed to read the Form S-4 registration statement (effective September 26, 2025), the related Prospectus (filed September 26, 2025), and Core Scientific's definitive Proxy Statement (filed and mailed on or about September 26, 2025) for important information.
• CoreWeave common stock and warrants (and underlying shares) are to be issued in connection with the proposed transaction.
• CoreWeave and Core Scientific, along with their respective directors and executive officers, may be deemed participants in the solicitation of proxies for the transaction.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural communication about an ongoing acquisition, primarily serving to direct investors to more detailed documents and outline associated risks. It does not present new positive or negative financial results.

Positives

• The communication confirms the ongoing progression of the proposed acquisition of Core Scientific by CoreWeave.
• The Form S-4 registration statement for the transaction was declared effective by the SEC on September 26, 2025, indicating regulatory progress.

Negatives

• The filing highlights numerous risks and uncertainties associated with the proposed transaction, which could cause actual results to differ materially from expectations.

Risks

• Completion of the proposed transaction on anticipated terms, or at all, and timing of completion, including obtaining Core Scientific stockholder approval.
• Uncertainty in the value of consideration Core Scientific stockholders would receive due to fluctuations in CoreWeave common stock market price.
• Unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the combined company.
• Possibility that anticipated benefits of the proposed transaction will not be realized or not within the expected time period.
• Ability of CoreWeave and Core Scientific to integrate businesses successfully and achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction against CoreWeave, Core Scientific, or their directors and officers.
• Disruptions from the proposed transaction harming CoreWeave's or Core Scientific's business, including current plans and operations.
• Diversion of management's time and attention to transaction-related issues.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Changes in local, national, or international laws, regulations, and policies affecting CoreWeave and Core Scientific.
• Potential business uncertainty, including commercial negotiations and changes to existing business relationships during the pendency of the transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue business opportunities or strategic transactions.
• Acts of terrorism, outbreak of war, hostilities, civil unrest, attacks, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• Transaction being more expensive to complete than anticipated due to unexpected factors or events.
• Impacts of pandemics or other public health crises and government responses.
• Global or regional changes in supply and demand for power and other market or economic conditions impacting demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including delays in converting crypto mining facilities to high-performance computing sites.

Future Outlook

The consummation of the proposed transaction and its anticipated benefits are subject to various risks and uncertainties. The combined company aims for successful business integration, achieving anticipated synergies, and value creation, but actual results may differ materially from current plans and expectations.

Management Comments

• Michael Intrator, Chief Executive Officer of CoreWeave, Inc., posted a communication on his LinkedIn account on October 7, 2025, in connection with CoreWeave's proposed acquisition of Core Scientific, Inc. and other acquisition activities.

Industry Context

The proposed acquisition involves companies operating in the artificial intelligence, power, data center, and crypto mining industries. The transaction reflects ongoing consolidation and strategic shifts within these sectors, particularly the conversion of crypto mining facilities to high-performance computing sites, which is a notable trend.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders: Core Scientific stockholders will receive CoreWeave common stock and warrants, subject to market price fluctuations. They are urged to read detailed filings for voting and investment decisions.
• Management: Time and attention of management will be diverted to transaction-related issues.
• Employees: Integration of businesses will impact employees of both companies.
• Business Relationships: Potential adverse reactions or changes to business relationships may result from the announcement or completion of the transaction.

Next Steps

• Core Scientific stockholders are urged to read the Form S-4, Proxy Statement, and Prospectus before making any voting or investment decision.
• Core Scientific stockholder approval for the proposed transaction is required.
• CoreWeave and Core Scientific aim to integrate their businesses successfully and achieve anticipated synergies.

Key Dates

Recommendation

This filing is a procedural update confirming the ongoing acquisition process and directing investors to comprehensive documents. It reiterates known risks associated with such transactions but does not introduce new financial data or strategic shifts that would alter an existing investment thesis. A 'hold' recommendation is appropriate as investors should await the full integration and performance of the combined entity, while carefully reviewing the detailed S-4, Proxy Statement, and Prospectus for specific terms and financial implications.

Keywords

CoreWeave, Core Scientific, Acquisition, Merger, SEC Filing, Form 425, S-4, Proxy Statement, Prospectus, Artificial Intelligence, Data Center, Crypto Mining, Corporate Governance, Risk Management